Biomet Inc., an orthopedic medical specialist, reported on Wednesday an increase of 5 percent in its net sales for its first quarter which ended August 31.

The maker of reconstructive medical products said its operating income increased by 2 percent. Net income increased 2.5 percent to $102,830,000 from $100,299,000 and rose by 6 percent on an adjusted basis to $106,815,000.

Biomet's reported earnings per share for the first quarter of fiscal yar 2007 were up 5 percent to $0.42 from $0.40.

"The Company's record first quarter results are attributable to continued strong sales of orthopedic reconstructive devices and dental reconstructive implants,' said Interim President and Chief Executive Officer Daniel P. Hann.

According to Biomet, the impact of foreign currency caused sales to rise by $3 million and net sales increased 4 percent. First quarter sales in the United States increased 3 percent, while international sales increased 7 percent on a constant currency basis.

Biomet has been designing and manufacturing products used primarily both surgical and non-surgical therapy for over 25 years and distributes its products to more than 100 countries worldwide.